News from egalet ltd A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

08:18 ET
Egalet Logo.

Egalet Announces Pricing of Public Offering of Common Stock

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

Jul 27, 2015, 16:11 ET
Egalet Logo.

Egalet Announces Proposed Public Offering of Common Stock

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

Jul 23, 2015, 06:00 ET
Egalet Logo.

Egalet to Host Conference Call and Webcast to Discuss Second Quarter 2015 Financial Results on August 6, 2015

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

Jul 01, 2015, 06:00 ET
Egalet Logo.

Egalet to Present at Upcoming Conferences This Summer

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

Jun 30, 2015, 06:00 ET
Egalet Logo

Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

Jun 29, 2015, 06:00 ET
Egalet Logo.

Egalet Announces Positive Top-Line Results from Intranasal Human Abuse Liability Study of Abuse-Deterrent Morphine, Egalet-001

 Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced positive results from a Category 3 intranasal human abuse liability (HAL) study...

Jun 25, 2015, 06:00 ET
Egalet Logo.

Egalet's Abuse-Deterrent, Extended-Release Morphine Demonstrates Bioequivalence at 60 mg Dose

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

Jun 23, 2015, 06:00 ET
Egalet Logo

Egalet Announces Launch of Specialty Pharmaceutical Sales Force

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

Jun 15, 2015, 06:05 ET
Egalet Logo

Egalet Corporation Appoints Timothy P. Walbert as Chairman of Board of Directors

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

Jun 04, 2015, 06:00 ET
May 28, 2015, 06:00 ET
Egalet Logo.

Egalet Category 1 Abuse-Deterrent Studies Demonstrated Strong Abuse-Deterrent Properties of Egalet-002 Compared to Reformulated OxyContin®

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

May 26, 2015, 06:00 ET
Egalet Logo.

Egalet to Present at Upcoming Conferences in June

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

May 19, 2015, 06:00 ET
Egalet Logo

Egalet Announces Issuance of U.S. Patents Covering Guardian™ Technology and Product Candidates

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

May 12, 2015, 06:00 ET
Egalet Logo.

Egalet President and Chief Executive Officer Bob Radie Appointed to Pennsylvania Bio Board of Directors

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

May 07, 2015, 06:00 ET
Egalet Logo

Egalet Reports First Quarter 2015 Financial Results and Provides Business Update

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

Apr 23, 2015, 06:00 ET
Egalet Logo

Egalet to Host Conference Call and Webcast to Discuss First Quarter 2015 Financial Results on May 7, 2015

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

Apr 13, 2015, 06:00 ET
Egalet Logo.

Egalet Appoints Nicholas Nicolaides, Ph.D. and John Osborn to Board of Directors

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

Apr 07, 2015, 16:01 ET
Egalet Logo

Egalet Announces Closing of $60 Million Offering of Convertible Senior Notes Due 2020

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

Apr 01, 2015, 09:51 ET
Egalet Logo.

Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020

 Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...

Mar 25, 2015, 06:00 ET
Egalet Logo

Egalet Provides Commercial Update on SPRIX® and OXAYDO™

Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and...